Good morning, everyone. Damian Garde here, filling in for Ed Silverman as the working week tilts toward almost over. The sun has crept into view after a sodden Tuesday, which will hopefully brighten your routine of meetings, deadlines, and requisite office small talk. To get you started, please find a few items of interest. And, as always, if you hear anything interesting, do let us know.

AbbVie (ABBV) is accused of using old-fashioned kickbacks to doctors and a stealthy network of nurses to illegally boost prescriptions of its best-selling Humira, STAT tells us. According to a lawsuit filed by the California insurance commissioner, AbbVie hired registered nurses to act as “ambassadors” to visit patients at home and help with administering the drug, but instead were used to ensure that prescriptions were continually refilled.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy